WELLS FARGO & COMPANY/MN
Position in AMLX — Amylyx Pharmaceuticals, Inc.
CIK 72971
SAN FRANCISCO, CA
Position in AMLX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$1,043,653
-$723,759 QoQ
Shares Held
75,083
-48.7% QoQ
Ownership
0.068%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 47%
Shared 0%
None 53%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $924,834,436 across 59 Drug Manufacturers - Specialty & Generic names. AMLX ranks #21 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,491,173 | $649,111,558 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
77,138 | $45,741,289 | |
| 3 | HLN |
Haleon plc
|
4,022,749 | $40,267,716 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
231,311 | $30,472,908 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,136,022 | $21,039,125 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
805,422 | $19,273,746 | |
| 7 | PBH |
Prestige Consumer Healthcare Inc.
|
300,133 | $17,788,881 | |
| 8 | VTRS |
Viatris Inc
|
1,160,097 | $15,672,908 |
All Filings in AMLX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,043,653 | 75,083 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $1,767,412 | 146,309 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,273,260 | 93,691 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $244,227 | 38,101 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,062 | 300 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,134 | 300 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $972 | 300 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $570 | 300 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $59,494 | 20,949 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $504,379 | 34,265 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $830,193 | 45,341 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,240,166 | 57,495 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $644,011 | 21,950 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $63,515 | 1,719 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $26,938 | 957 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $30,391 | 1,578 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,154,237 | 89,824 | Shares | Defined | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||